
By Elvia Limón, Laura Blasey and Amy Hubbard Hello, it’s Wednesday, March 23, and here are the stories you shouldn’t miss today: TOP STORIES Ukrainians go on the counteroffensive Ukrainian forces defending the capital, Kyiv, managed to wrest back control of a strategic outlying town that Russian troops had earlier captured, Ukrainian officials said, but

Protective Asset Protection’s mother or father business will obtain Protective’s rival finance and insurance policies merchandise service provider AUL Corp. Phrases of the acquisition were being not disclosed in the Monday announcement by Protective Lifetime Corp. Protecting Life expects the deal to close in the 2nd quarter. Protective Daily life Senior Vice President M. Scott

You cannot set a label on Kim Kardashian. Given that stepping into the spotlight with her activity-transforming fact series Retaining Up With the Kardashians in 2007, Kardashian has turn out to be a television fixture, shapewear entrepreneur, social media innovator, criminal justice activist, regulation student, designer muse, and mother. Established to share but one more side of

When Guillermo del Toro’s Blade II strike theaters 20 many years back this thirty day period, it was a much-wanted crucial and commercial hit for the filmmaker, chalking up $155 million throughout the world and far better-than-ordinary reviews. This is not the story of that movie. It is the story of 1 of these reviews—quite

Numerous of the ads are operate by the “news and media website” Ukraine War, when some others are run by the “social media agency” Safe Ukraine. They consist of emotive movies of captured Russian soldiers tearfully contacting their mothers and fathers back again household to expose the fact of what war is like, alongside textual

By LAURAN NEERGAARD, AP Medical Writer Moderna’s COVID-19 vaccine will work in infants, toddlers and preschoolers the organization announced Wednesday — and if regulators concur it could mean a prospect to at last start off vaccinating the littlest children by summer. Moderna explained in the coming months it would check with regulators in the U.S.